The evolution of personalized healthcare and the pivotal role of European regions in its implementation
| Autor: | Mauro Turrini, Wolfgang Ballensiefen, Gianni D'Errico, Christos Lionis, Christine Nardini, Elio Borgonovi, Venet Osmani, Thomas Neumuth, Paola Giulia Cormio, Andrea Frosini |
|---|---|
| Přispěvatelé: | Turrini, Mauro, Turrini, Mauro [0000-0001-8589-3271] |
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Big Data Biomedical Research Interdisciplinary Research health data local and regional authorities Health data 03 medical and health sciences 0302 clinical medicine Patient-Centered Care Health care Humans Precision Medicine Pace Pharmacology Local Government business.industry Stakeholder General Medicine European Partnership on Personalized Medicine personalized medicine Public relations 3. Good health Europe 030104 developmental biology healthcare governance 030220 oncology & carcinogenesis personalized healthcare Key (cryptography) Molecular Medicine Personalized medicine Health Services Research business |
| Zdroj: | Digital.CSIC. Repositorio Institucional del CSIC instname Personalized medicine 18 (2021): 283–294. doi:10.2217/pme-2020-0115 info:cnr-pdr/source/autori:Nardini, Christine; Osmani, Venet; Cormio, Paola G.; Frosini, Andrea; Turrini, Mauro; Lionis, Christos; Neumuth, Thomas; Ballensiefen, Wolfgang; Borgonovi, Elio; D'Errico, Gianni/titolo:The evolution of personalized healthcare and the pivotal role of European regions in its implementation/doi:10.2217%2Fpme-2020-0115/rivista:Personalized medicine (Print)/anno:2021/pagina_da:283/pagina_a:294/intervallo_pagine:283–294/volume:18 |
| ISSN: | 1744-828X |
| DOI: | 10.2217/pme-2020-0115 |
| Popis: | Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare and their evolution through scientific publications where a clear definition and the features of the different formulations are identifiable. We then examined PM policy documents of the International Consortium for Personalised Medicine and related initiatives to understand how PM stakeholders have been changing. Regional authorities and stakeholders have joined the race to deliver personalized care and are driving toward what could be termed as the next personalized healthcare. Their role as a key stakeholder in PM is expected to be pivotal. The Coordination and Support Action Regions4PerMed has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 825812. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|